Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-REMI trial: CNS7056 in Japanese pediatric patients undergoing general anesthesia
jRCT2031230657Phase 1Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of remimazolam, sponsored by Japan Agency for Medical Research and Development. Started Jul 2024; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT2031230657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230657.